Schroeder H G, DeLuca P P
Am J Hosp Pharm. 1976 Jun;33(6):543-6.
Particulate contamination levels of a base intravenous solution and five admixtures were assessed in a double-blind study conducted to determine the effect of inline i.v. filtration on infusion phlebitis. Only a qualitative evaluation on actual patient filters was possible due to deformation of the filter membrane after 72 hours; simulation of i.v. therapy in the laboratory gave more reliable information about particle counts and distribution. The base solution was dextrose 5% in 0.2% sodium chloride injection; the admixtures contained this base solution and the following additives (per liter): (1) 20 mEq potassium chloride, (2) 20 mEq potassium chloride and 2 ml vitamin B complex, (3) 20 mEq potassium chloride and 5 million units of potassium penicillin G, (4) 20 mEq potassium chloride and 1 g cephalothin sodium (delivered in a 100-ml volume from a medication chamber), and (5) 30 mEq potassium chloride and 3 million units of penicillin G (delivered every four hours from a medication chamber) and 80 mg of gentamicin sulfate (delivered every eight hours from a medication chamber). None of the six i.v. infusion schedules simulated exceeded the standards for particulate matter prescribed by the USP XIX. As expected, however, the particle counts increased as a function of the additives used in the simulation, particularly with the antibiotics.
在一项双盲研究中评估了一种基础静脉输液溶液和五种混合液的微粒污染水平,该研究旨在确定在线静脉过滤对输液性静脉炎的影响。由于72小时后滤膜变形,只能对实际患者使用的过滤器进行定性评估;在实验室模拟静脉治疗可获得关于颗粒计数和分布的更可靠信息。基础溶液为0.2%氯化钠注射液中含5%葡萄糖;混合液含有该基础溶液和以下添加剂(每升):(1)20毫当量氯化钾,(2)20毫当量氯化钾和2毫升复合维生素B,(3)20毫当量氯化钾和500万单位青霉素G钾,(4)20毫当量氯化钾和1克头孢噻吩钠(从药室以100毫升体积提供),以及(5)30毫当量氯化钾和300万单位青霉素G(每四小时从药室提供)和80毫克硫酸庆大霉素(每八小时从药室提供)。模拟的六种静脉输液方案均未超过美国药典第十九版规定的微粒物质标准。然而,正如预期的那样,颗粒计数随着模拟中使用的添加剂数量增加而增加,尤其是使用抗生素时。